Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity-Reference-Cited by-同舟云学术

Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severity

Published:2020 Issue: Volume:3 Page:100046
ISSN:2590-1125
Container-title:Clinical Parkinsonism & Related Disorders
language:en
Short-container-title:Clinical Parkinsonism & Related Disorders

Author:

Dahodwala Nabila,Pettit Amy R.,Jahnke Jordan,Li Pengxiang,Ladage Vrushabh P.,Kandukuri Prasanna L.,Zamudio Jorge,Jalundhwala Yash J.,Doshi Jalpa A.

Funder

AbbVie

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030;Dorsey;Neurology,2007

2. Prevalence of Parkinson’s disease across North America;Marras;NPJ Parkinsons Dis.,2018

3. Developing consensus among movement disorder specialists on clinical indicators for identification and management of advanced Parkinson’s disease: a multi-country Delphi-panel approach;Antonini;Curr. Med. Res. Opin.,2018

4. Burden of illness in Parkinson’s disease;Huse;Mov. Disord.,2005

5. Health, United States, 2013: With Special Featureon Prescription Drugs;National Center for Health Statistics,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tools and criteria to select patients with advanced Parkinson’s disease for device-aided therapies: a narrative review;Journal of Neural Transmission;2023-07-27

2. Towards improved access to device-aided therapies in advanced PD: the importance of cooperation of different disciplines;Journal of Neural Transmission;2023-07-13

3. Advanced‐Stage Parkinson's Disease: From Identification to Characterization Using a Nationwide Database;Movement Disorders Clinical Practice;2022-04-29

4. Comparative Effectiveness of Carbidopa–Levodopa Enteral Suspension and Deep Brain Stimulation on Parkinson’s Disease-Related Pill Burden Reduction in Advanced Parkinson’s Disease: A Retrospective Real-World Cohort Study;Neurology and Therapy;2022-04-20

5. The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel in the Treatment of Advanced Parkinson’s Disease in England;PharmacoEconomics;2022-03-21